Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 15.20
-0.60 (-3.80%)
Jun 2, 2026, 5:30 PM CET
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 94 employees as of December 31, 2025. The number of employees increased by 15 or 19.24% compared to the previous year.
Employees
94
Change (1Y)
15
Growth (1Y)
19.24%
Revenue / Employee
821.12K CHF
Profits / Employee
-523.79K CHF
Market Cap
212.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 94 | 15 | 19.24% |
| Dec 31, 2024 | 79 | 34 | 75.22% |
| Dec 31, 2023 | 45 | -1 | -2.18% |
| Dec 31, 2022 | 46 | 6 | 16.24% |
| Dec 31, 2021 | 39 | -47 | -54.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,595 |
| Idorsia | 487 |
| Basilea Pharmaceutica AG | 189 |
| Molecular Partners AG | 134 |
| BioVersys AG | 33 |
| Newron Pharmaceuticals | 27 |
| Xlife Sciences AG | 17 |
| Addex Therapeutics | 2 |
Santhera Pharmaceuticals Holding AG News
- 5 weeks ago - Santhera Pharmaceuticals Holding AG Earnings Call Transcript: H2 2025 - Transcripts
- 5 weeks ago - Santhera Pharmaceuticals Holding AG Annual report: H2 2025 - Filings
- 5 weeks ago - Santhera Pharmaceuticals Holding AG Earnings release: H2 2025 - Filings
- 5 weeks ago - Santhera Pharmaceuticals Holding AG Slides: H2 2025 - Filings
- 5 weeks ago - Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025 - GlobeNewsWire
- 9 months ago - Santhera Pharmaceuticals Holding AG Earnings Call Transcript: H1 2025 - Transcripts
- 9 months ago - Santhera Pharmaceuticals Holding AG Quarterly report: H1 2025 - Filings
- 9 months ago - Santhera Pharmaceuticals Holding AG Slides: H1 2025 - Filings